ToI Podcast

Daily Briefing Nov. 16: Mixed reactions for 25th Knesset; MDs use new tumor tech

Knesset correspondent Carrie Keller-Lynn discusses the new parliament and activists at COP27, as health and science reporter Nathan Jeffay looks at sperm count research, tumor tech

Welcome to The Times of Israel’s Daily Briefing, your 15-minute audio update on what’s happening in Israel, the Middle East and the Jewish world, from Sunday through Thursday.

Knesset correspondent Carrie Keller-Lynn and health and science reporter Nathan Jeffay join host Jessica Steinberg for today’s podcast.

Keller-Lynn talks about Tuesday’s swearing-in of the 25th Knesset, as newcomers celebrated their wins, and the opposition warned of the end of democracy.

Keller-Lynn also discusses the lack of outside activists at the ongoing United Nations Climate Conference COP27 in Egypt’s Sharm el-Sheikh, part of the Egyptian efforts to quash the usual protests.

Jeffay speaks about a Hebrew University study that examines plummeting sperm counts worldwide, which could point to a wider decline in aspects of men’s health. He also looks at a new technology under trial which offers a fuller report on the DNA of tumors.

Discussed articles include:

Far-right vows upped security under new gov’t; Liberman warns of ‘ayatollah regime’

Sperm counts worldwide have plunged 62% in under 50 years, Israeli-led study finds

Egyptians keep tight leash on climate confab, muffling traditional din of protests

Israeli hospital: New tech gave instant DNA info on tumors, jump-starts treatment

Subscribe to The Times of Israel Daily Briefing on iTunesSpotifyPlayerFM, Google Play, or wherever you get your podcasts.

Check out yesterday’s Daily Briefing episode:


read more:
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
Register for free
and continue reading
Registering also lets you comment on articles and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure:
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.